Public Can Weigh In Next Week on Candidates for New Chair of $12 Billion California Stem Cell Agency
The position is a key to future direction of the program and its survival
No. 13 is a big item coming up next week for the 35-member governing board of the $12 billion California stem cell and gene therapy agency.
That is the number of the agenda item involving the election of a new chair for the nearly 18-year-old enterprise. It is seeking to bring what some consider miraculous therapies to the people of California, who are f…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.